Newsmv
The White House moved aggressively to deny that President Donald Trump received exclusive access to a weight loss drug, responding directly to a report from STAT News.
STAT News reported that Eli Lilly and the Food and Drug Administration granted a 79-year-old man exclusive access to the drug after a request was made in April.
What STAT News Reported STAT News, a publication that covers the pharmaceutical industry and federal health agencies, reported that Eli Lilly and the FDA facilitated singular access to a weight loss drug for a 79-year-old man.
The initiating event, per the report, was a request made in April. The report did not, in the summary available, name the individual directly — but the White House's swift and forceful denial made the implication clear.
Keep reading